Impax Labs challenges Vytorin patents – BusinessWeek
Impax Labs challenges Vytorin patents
BusinessWeek
LLC’s patents on the cholesterol drug Vytorin. Impax has asked for Food and Drug Administration approval to make a generic version of the drug. …
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mgMarketWatch (press release)
Impax challenges cholesterol drug patentsSan Francisco Business Times
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mgTrading Markets (press release)
all 32 news articles
